The Research and Development Center was formally accepted
At the beginning of January 2024, we signed the final acceptance protocol of the Research and Development Center (CBR) with the general contractor.
New contracts from Barcelona
The Synthaverse team wouldn’t miss the largest event in the pharmaceutical world - the CPHI Worldwide fair in Barcelona.
Management board priorities after a year
It’s been a year since Mieczysław Starkowicz has become the president of the company's management board. What were the most important events during this time?
CBR building is finally open
On September 20, 2023, we received the occupancy permit for the Biotechnology Innovation Center - Onko BCG Plant.
We are Synthaverse
Biomed Lublin changes its name to Synthaverse and presents a new branding.